Browse diseases

…y-one patients (89% women) with chronic (93%) and episodic (7%) migraine were included, with a mean age of 44 [range 23–62] years. All s…

…ents had chronic migraine, while 5 (7.9%) patients had episodic migraine. Regarding previous treatments, 56 (88.9%) patients had receive…

… divide in terms of emergency and elective admissions. Regional migraine service provision and health inequalities may account for the d…

… establish the potentially therapeutic targets in patients with migraine from a multidisciplinary point of view.Ethics and dissemination…

…ts calcitonin gene-related peptide (CGRP) receptors involved in migraine development.Aim and Objectives To evaluate atogepant effectiven…

…, anti-CGRP mAbs were associated with significant reductions in migraine frequency after 6 months. Galcanezumab showed the greatest mean…

…event stroke if TIA is treated as migraine, or overtreatment if migraine is treated as TIA. This project aims to define the risk of stro…

…Background Migraine is a common comorbidity in patients with cervical dystonia (CD); however, the diagnosis of chronic migraine (CM) in patien…

… points) and MIDAS (≥4.5 points) over 24 months in a real-world migraine cohort, and to characterise patient demographics and treatment …

…ptor antagonists (atogepant, rimegepant) are drugs indicated in migraine prophylaxis in adults. These treatments have proven effective i…

… direct and indirect costs (all p<0.001).Conclusion People with migraine and active depression experience higher humanistic and economic…

…luate if anti-CGRP mAbs can modulate the CGRP concentrations in migraine patients.…